Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CollPlant Biotechnologies...

    NASDAQ: CLGN · Real-Time Price · USD
    2.04
    -0.16 (-7.27%)
    At close: Jun 05, 2025, 3:59 PM
    2.12
    3.69%
    Pre-market: Jun 06, 2025, 09:19 AM EDT

    CollPlant Biotechnologies Statistics

    Share Statistics

    CollPlant Biotechnologies has 11.45M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 11.45M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.03%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 462

    FTD / Avg. Volume

    n/a
    		 0.63%

    Short Selling Information

    The latest short interest is 2.08K, so 0.02% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.08K

    Short % of Shares Out

    n/a
    		 0.02%

    Short % of Float

    n/a
    		 0.03%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -2.48 and the forward PE ratio is 221.12. CollPlant Biotechnologies's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -2.48

    Forward PE

    n/a
    		 221.12

    PS Ratio

    n/a
    		 80.07

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 3.06

    P/FCF Ratio

    n/a
    		 -2.83

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for CollPlant Biotechnologies.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.44, with a Debt / Equity ratio of 0.23.

    Current Ratio

    n/a
    		 4.44

    Quick Ratio

    n/a
    		 4.29

    Debt / Equity

    n/a
    		 0.23

    Debt / EBITDA

    n/a
    		 -0.19

    Debt / FCF

    n/a
    		 -0.21

    Interest Coverage

    n/a
    		 -1014.76

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $9,035.09

    Profits Per Employee

    n/a
    		 $-291,385.96

    Employee Count

    n/a
    		 57

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 3.69

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -61.51% in the last 52 weeks. The beta is 0.86, so CollPlant Biotechnologies's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.86

    52-Week Price Change

    n/a
    		 -61.51%

    50-Day Moving Average

    n/a
    		 2.28

    200-Day Moving Average

    n/a
    		 3.63

    Relative Strength Index (RSI)

    n/a
    		 46.77

    Average Volume (20 Days)

    n/a
    		 73,606

    Income Statement

    In the last 12 months, CollPlant Biotechnologies had revenue of 515K and earned -16.61M in profits. Earnings per share was -1.45.

    Revenue

    n/a
    		 515K

    Gross Profit

    n/a
    		 -1.11M

    Operating Income

    n/a
    		 -17.25M

    Net Income

    n/a
    		 -16.61M

    EBITDA

    n/a
    		 -16.21M

    EBIT

    n/a
    		 -17.25M

    Earnings Per Share (EPS)

    n/a
    		 -1.45
    Full Income Statement

    Balance Sheet

    The company has 11.91M in cash and 3.08M in debt, giving a net cash position of 8.83M.

    Cash & Cash Equivalents

    n/a
    		 11.91M

    Total Debt

    n/a
    		 3.08M

    Net Cash

    n/a
    		 8.83M

    Retained Earnings

    n/a
    		 -113.35M

    Total Assets

    n/a
    		 18.71M

    Working Capital

    n/a
    		 10.21M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.09M and capital expenditures -483K, giving a free cash flow of -14.58M.

    Operating Cash Flow

    n/a
    		 -14.09M

    Capital Expenditures

    n/a
    		 -483K

    Free Cash Flow

    n/a
    		 -14.58M

    FCF Per Share

    n/a
    		 -1.27
    Full Cash Flow Statement

    Margins

    Gross margin is -215.53%, with operating and profit margins of -3349.71% and -3225.05%.

    Gross Margin

    n/a
    		 -215.53%

    Operating Margin

    n/a
    		 -3349.71%

    Pretax Margin

    n/a
    		 -3225.05%

    Profit Margin

    n/a
    		 -3225.05%

    EBITDA Margin

    n/a
    		 -3148.16%

    EBIT Margin

    n/a
    		 -3349.71%

    FCF Margin

    n/a
    		 -2830.29%

    Dividends & Yields

    CLGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLGN is $12, which is 488.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 488.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 1, 2016. It was a backward split with a ratio of 2:3.

    Last Split Date

    n/a
    		 Dec 1, 2016

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 2:3

    Scores

    Altman Z-Score

    n/a
    		 -6.39

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist